Journey Medical Corporation
DERM
$5.29
-$0.02-0.38%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -4.25% | -12.42% | 7.11% | -4.17% | -4.76% |
| Total Other Revenue | -- | -- | -- | -100.00% | 26,283.56% |
| Total Revenue | -57.64% | -13.49% | 6.69% | -4.44% | 114.31% |
| Cost of Revenue | -17.79% | -15.78% | 5.69% | -22.07% | -10.97% |
| Gross Profit | -66.76% | -11.60% | 7.81% | 12.05% | 216.02% |
| SG&A Expenses | 31.96% | -14.93% | -36.65% | -29.64% | -44.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.32% | -17.99% | 6.18% | -33.13% | -32.47% |
| Operating Income | -116.78% | 35.10% | -5.53% | 78.95% | 281.68% |
| Income Before Tax | -114.16% | 59.81% | -3.02% | 81.02% | 267.67% |
| Income Tax Expenses | -- | -- | -- | 869.23% | 850.00% |
| Earnings from Continuing Operations | -114.24% | 59.81% | -3.02% | 79.86% | 266.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -114.24% | 59.81% | -3.02% | 79.86% | 266.56% |
| EBIT | -116.78% | 35.10% | -5.53% | 78.95% | 281.68% |
| EBITDA | -111.52% | 38.62% | -9.23% | 85.30% | 313.06% |
| EPS Basic | -112.77% | 63.81% | 7.15% | 80.91% | 259.34% |
| Normalized Basic EPS | -118.67% | 42.00% | 7.17% | 82.01% | 260.41% |
| EPS Diluted | -115.00% | 63.81% | 7.15% | 80.16% | 239.84% |
| Normalized Diluted EPS | -121.33% | 42.00% | 7.17% | 82.01% | 240.45% |
| Average Basic Shares Outstanding | 11.52% | 11.05% | 10.95% | 5.44% | 4.53% |
| Average Diluted Shares Outstanding | -2.36% | 11.05% | 10.95% | 5.44% | 19.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
